Amit Hasija
Director of Finance/CFO at MILESTONE PHARMACEUTICALS INC.
Net worth: 7 310 $ as of 30/03/2024
Profile
Amit Hasija is currently the CFO & Executive VP-Corporate Development at Milestone Pharmaceuticals, Inc. He is also the Treasurer at Milestone Pharmaceuticals USA, Inc. Previously, he worked as an Operations Manager at Merck & Co., Inc. from 1995 to 2000.
From 2012 to 2017, he was the Vice President-Pharmaceutical Business Development at Sanofi.
He then served as the Chief Financial & Business Officer at Fulcrum Therapeutics, Inc. from 2017 to 2019.
Mr. Hasija received his undergraduate degree from Drexel University in 1995 and his MBA from The Leonard N Stern School of Business in 2002.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2023 | 4,084 ( 0.01% ) | 7 310 $ | 30/03/2024 |
Amit Hasija active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director of Finance/CFO | 08/09/2019 |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The private company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Treasurer | - |
Former positions of Amit Hasija
| Companies | Position | End |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Director of Finance/CFO | 31/12/2018 |
| SANOFI | Corporate Officer/Principal | 31/12/2016 |
| MERCK & CO., INC. | Chief Operating Officer | 31/12/1999 |
Training of Amit Hasija
| Drexel University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANOFI | Commercial Services |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The private company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Amit Hasija
